Could a new injection tame ulcerative colitis?
NCT ID NCT07758101
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental drug called SHR-7590 to see if it is safe and tolerable when given by injection under the skin or into a vein. It involves healthy volunteers and people with moderate-to-severe ulcerative colitis, a condition that causes inflammation and sores in the colon. The study will also look at how the drug moves through the body and how it affects the disease. The goal is to gather initial information that could support further development of SHR-7590 as a potential treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SHR-7590, an experimental drug given by injection under the skin or into a vein
- What this could lead to
- If safe and effective, SHR-7590 could become a new treatment option to control inflammation and reduce symptoms in people with ulcerative colitis.
- What could go wrong
- This is an early, first-in-human study with a small number of participants, so safety and effectiveness are not yet established. The drug may cause side effects or fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame ulcerative colitis?
- New study explores simple tests to replace colonoscopies for colitis patients
- New pill could tame severe gut disease
- New drug shows promise for ulcerative colitis sufferers
- Immune cell therapy takes on IBD: a new hope for tough cases?
- New drug vixarelimab tested for Tough-to-Treat ulcerative colitis